Low-dose hexavalent chromium(VI) exposure promotes prostate cancer cell proliferation by activating MAGEB2-AR signal pathway.

导出 LinkOut

翻译打印收藏纠错

第一作者： Yunkai,Qie

第一单位： Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China; CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.

作者： Yunkai,Qie ^[1] ; Diansheng,Zhou ^[2] ; Zhouliang,Wu ^[2] ; Shenglai,Liu ^[2] ; Chong,Shen ^[2] ; Hailong,Hu ^[2] ; Changwen,Zhang ^[3] ; Yong,Xu ^[4]

作者单位： Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China; CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China. ^[1] Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China. ^[2] Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China. Electronic address: changwenzhang0329@126.com. ^[3] Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China. Electronic address: yxurologist@163.com. ^[4]

关键词 DNA Epigenetics Hexavalent chromium Hypomethylation MAGEB2 Prostate cancer